Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 05, 2015 1:34 PM ET

Healthcare Equipment and Supplies

Company Overview of Lantheus Holdings, Inc.

Company Overview

Lantheus Holdings, Inc. develops, manufactures, sells, and distributes diagnostic imaging agents and products, primarily used to diagnose cardiovascular diseases worldwide. Its principal products include the echocardiography contrast agent, DEFINITY Vial, for (perflutren lipid microsphere) injectable suspension; TechneLite (technetium Tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. The company also offers ABLAVAR to evaluate aortoiliac occlusive disease in adults; Cardiolite to...

331 Treble Cove Road

North Billerica, MA 01862

United States

Founded in 1956

524 Employees

Phone:

978-667-9531

Fax:

978-671-8860

Key Executives for Lantheus Holdings, Inc.

Chief Executive Officer, President and Director
Age: 55
Total Annual Compensation: $353.8K
Chief Financial Officer
Age: 53
Total Annual Compensation: $215.4K
Chief Medical Officer
Age: 65
Total Annual Compensation: $372.6K
Vice President, General Counsel and Secretary
Age: 54
Total Annual Compensation: $328.2K
Consultant
Age: 52
Total Annual Compensation: $484.6K
Compensation as of Fiscal Year 2014.

Lantheus Holdings, Inc. Key Developments

Lantheus Holdings, Inc. Announces Executive Changes

Lantheus Holdings, Inc. announced the appointment of Mary Anne Heino as the new President and Chief Executive Officer and a director of the company. Ms. Heino replaces Jeff Bailey, who has served as President and Chief Executive Officer and a director of the company since January 2013 and is retiring from operational management to focus on Board positions. Mr. Bailey will continue with the company on a consulting basis until March 31, 2016 and will work with Ms. Heino to ensure a smooth transition. Ms. Heino, age 55, brings to the company more than 25 years of diverse pharmaceutical industry experience. Joining the Company in April 2013 as Chief Commercial Officer, Ms. Heino was promoted to Chief Operating Officer in March 2015.

Lantheus Medical Imaging, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for Full-Year 2015; Announces Asset Write-Off for the Second Quarter Ended June 30, 2015

Lantheus Medical Imaging, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company announced revenues of $73,314,000 compared to $75,613,000 for the same period a year ago. Operating income was $5,356,000 compared to $9,980,000 for the same period a year ago. Loss before income taxes was $23,248,000 compared to $762,000 for the same period a year ago. Net loss was $24,423,000 or $1.29 per basic and diluted share compared to $1,636,000 or $0.09 per basic and diluted share for the same period a year ago. Net income, as adjusted was $882,000 or $0.05 per basic and diluted share compared to net loss, as adjusted of $1,636,000 or $0.09 per basic and diluted share for the same period a year ago. LBITDA was $6,238,000 compared to EBITDA of $14,235,000 for the same period a year ago. Adjusted EBITDA was $17,985,000 compared to $16,317,000 for the same period a year ago. Net cash used in operating activities was $11,438,000 compared to $4,988,000 for the same period a year ago. Capital expenditures were $2,614,000 compared to $1,998,000 for the same period a year ago. For the six months, the company announced revenues of $148,137,000 compared to $148,949,000 for the same period a year ago. Operating income was $16,734,000 compared to $18,469,000 for the same period a year ago. Loss before income taxes was $22,876,000 compared to $3,239,000 for the same period a year ago. Net loss was $24,048,000 or $1.30 per basic and diluted share compared to $2,921,000 or $0.16 per basic and diluted share for the same period a year ago. Net income, as adjusted was $4,887,000 or $0.26 per basic and diluted share compared to net loss, as adjusted of $2,921,000 or $0.16 per basic and diluted share for the same period a year ago. EBITDA was $12,345,000 compared to $27,001,000 for the same period a year ago. Adjusted EBITDA was $38,572,000 compared to $32,335,000 for the same period a year ago. Net cash from operating activities was $3,719,000 compared to net cash used in operating activities of $5,048,000 for the same period a year ago. Capital expenditures were $6,112,000 compared to $3,480,000 for the same period a year ago. For the quarter, the company announced asset write-off of $371,000 compared to $91,000 for the same period a year ago. For full-year 2015, the company anticipates worldwide revenue of approximately $293 million to $297 million, representing a constant currency change over last year of (1)% to 1%. This range assumes a negative full-year impact from currency of approximately $6 million, or 2%, compared to 2014. The company anticipates adjusted EBITDA, as described in the GAAP to non-GAAP reconciliation provided later in this release, of $72 million to $75 million, and 24% to 25% of reported revenue.

Lantheus Holdings, Inc., Q2 2015 Earnings Call, Aug 04, 2015

Lantheus Holdings, Inc., Q2 2015 Earnings Call, Aug 04, 2015

Similar Private Companies By Industry

Company Name Region
Wright Medical Technology, Inc. United States
HealthTech Services Corporation United States
Shepard Medical Products, Inc. United States
Boulder BioMed, Inc. United States
Technical Services for Electronics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lantheus Holdings, Inc., please visit investor.lantheus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.